The innervation of the human prostate gland--the changes associated with benign enlargement
- PMID: 1719253
- DOI: 10.1016/s0022-5347(17)38203-4
The innervation of the human prostate gland--the changes associated with benign enlargement
Abstract
Different regions of the prostate gland, namely prostatic capsule, peripheral prostate and central prostate (subdivided into proximal (near the bladder neck), distal (near the verumontanum) and midway between these areas) were obtained from 32 obstructed (stable obstructed, n = 8; unstable obstructed, n = 13; acute retention, n = 11) and five control patients. The innervation of these tissues was studied both histochemically to localise acetylcholinesterase activity and immunohistochemically for dopamine-beta-hydroxylase, 5-hydroxytryptamine, vasoactive intestinal polypeptide, neuropeptide Y, leu- and met-enkephalin, calcitonin gene-related peptide, substance P and somatostatin. In control patients the greatest density of nerves was found in the proximal central prostate, followed by the anterior capsule and distal central prostate, with the least density in the peripheral prostate. The greatest density of nerves were acetylcholinesterase positive and immunoreactive to neuropeptide Y followed (in decreasing order) by nerves immunoreactive to: vasoactive intestinal polypeptide and dopamine beta-hydroxylase; leu-enkephalin and 5-hydroxytryptamine; calcitonin gene-related peptide; met-enkephalin; substance P; somatostatin. In addition a group of periacinar 5-hydroxytryptamine-immunoreactive cells and ganglia containing acetylcholinesterase, dopamine beta-hydroxylase and all of the peptides studied except somatostatin were identified. In the prostate gland from obstructed patients there was a significant reduction in the density of acetylcholinesterase-positive nerves (p less than 0.001) when compared with the controls. A similar trend was found for dopamine beta-hydroxylase, 5-hydroxytryptamine and all of the putative neuropeptides in most areas of the prostate, the most notable exceptions being in the peripheral prostate, with an increase in dopamine beta-hydroxylase- and leu-enkephalin-immunoreactive nerves in all three groups of obstructed patients an an increase in vasoactive intestinal polypeptide- and calcitonin gene-related peptide-immunoreactive nerves in those presenting in urinary retention. The functional significance of these findings is discussed.
Similar articles
-
Development of peptide-containing nerves in the human fetal prostate gland.J Anat. 1995 Aug;187 ( Pt 1)(Pt 1):169-79. J Anat. 1995. PMID: 7591978 Free PMC article.
-
Peptide-containing neurons in different regions of the submucous plexus of human sigmoid colon.Gastroenterology. 1992 Feb;102(2):461-7. doi: 10.1016/0016-5085(92)90091-c. Gastroenterology. 1992. PMID: 1370660
-
The human prostate gland: a histochemical and immunohistochemical study of neuropeptides, serotonin, dopamine beta-hydroxylase and acetylcholinesterase in autonomic nerves and ganglia.Br J Urol. 1991 Jul;68(1):53-61. doi: 10.1111/j.1464-410x.1991.tb15257.x. Br J Urol. 1991. PMID: 1873692
-
The human penis: an unusual penetration of NPY-immunoreactive nerves within the medial muscle coat of the deep dorsal vein.J Urol. 1991 Jun;145(6):1292-6. doi: 10.1016/s0022-5347(17)38617-2. J Urol. 1991. PMID: 2033719
-
Cholinergic innervation and function in the prostate gland.Pharmacol Ther. 2002 Apr-May;94(1-2):93-112. doi: 10.1016/s0163-7258(02)00174-2. Pharmacol Ther. 2002. PMID: 12191596 Review.
Cited by
-
Novel drug targets for the pharmacotherapy of benign prostatic hyperplasia (BPH).Br J Pharmacol. 2011 Jul;163(5):891-907. doi: 10.1111/j.1476-5381.2011.01332.x. Br J Pharmacol. 2011. PMID: 21410684 Free PMC article. Review.
-
New therapeutic targets to prevent benign prostatic enlargement and symptomatic progression to benign prostatic obstruction-ICI-RS 2023.Neurourol Urodyn. 2024 Aug;43(6):1363-1371. doi: 10.1002/nau.25326. Epub 2023 Nov 2. Neurourol Urodyn. 2024. PMID: 37916442 Free PMC article. Review.
-
Age-related changes in the innervation of the prostate gland: implications for prostate cancer initiation and progression.Organogenesis. 2013 Jul-Sep;9(3):206-15. doi: 10.4161/org.24843. Epub 2013 May 14. Organogenesis. 2013. PMID: 23872639 Free PMC article. Review.
-
Observational study: daily treatment with a new compound "Tradamixina" plus serenoa repens for two months improved the lower urinary tract symptoms.BMC Surg. 2012;12 Suppl 1(Suppl 1):S22. doi: 10.1186/1471-2482-12-S1-S22. Epub 2012 Nov 15. BMC Surg. 2012. Retraction in: BMC Surg. 2016 Apr 28;16(1):23. doi: 10.1186/s12893-016-0139-0. PMID: 23173650 Free PMC article. Retracted. Clinical Trial.
-
A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds.Rev Sci Instrum. 2009 Oct;80(10):104301. doi: 10.1063/1.3242697. Rev Sci Instrum. 2009. PMID: 19895076 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous